Sign in

You're signed outSign in or to get full access.

Gary Stetz

Director at Tharimmune
Board

About Gary Stetz

Gary Stetz (age 62) was appointed as an independent director of Tharimmune in April 2025. He is a Certified Public Accountant with 35+ years in accounting, finance, valuation, and corporate governance, and Managing Partner at Stetz, Belgiovine, Manwarren and Wallis P.C. (serving 1,000+ corporate clients). He founded Allegiance Community Bank and served on the board of BCB Bancorp; he co-authored “Project Management Accounting,” and holds credentials including Certified Mediator, Certified Fraud Examiner, and Chartered Global Management Accountant . His academic background includes Rutgers University (Accounting and Finance), University of Notre Dame (MBA), and Corpus Christi College, Oxford .

Past Roles

OrganizationRoleTenureCommittees/Impact
Stetz, Belgiovine, Manwarren and Wallis P.C.Managing PartnerNot disclosedLed accounting/audit/tax advisory; firm serves 1,000+ corporate clients
Allegiance Community BankFounder/Vice Chairman (historical)Not disclosedBank later merged into BCB Community Bank
BCB Bancorp (NASDAQ: BCBP)Director; Audit Committee Chair/“financial expert”2011–at least 2018Chaired Audit Committee; designated audit “financial expert”; audit committee met 11–16 times annually

External Roles

OrganizationRoleTenureNotes
BCB Bancorp (NASDAQ: BCBP)Director; Audit Committee leadership2011–2018 (disclosed)Audit committee chair/financial expert
Partners for Women and Justice; Immaculate Conception HS; New Found LifeBoard roles (non-profit)Not disclosedAs disclosed in BCBP proxies

Board Governance

  • Independence: The THAR Board determined Gary Stetz is independent under SEC/Nasdaq rules .
  • Committees: THAR maintains audit, compensation, and nominating/governance committees; responsibilities include auditor oversight, pay policies, and director nominations . As of Dec 31, 2024, committee compositions were reported without Stetz (appointed April 2025); post-appointment committee assignments were not disclosed in the proxy .
  • Attendance: In FY2024, the Board held 6 meetings; audit 4; compensation 4; nominating/governance 1. No director serving in 2024 attended less than 75% of applicable meetings (Stetz joined in 2025; thus not included) .
  • Anti‑hedging/pledging: Directors, officers, employees, and consultants are prohibited from short sales and hedging; pledging requires pre‑clearance. As of Dec 31, 2024, no directors or executives had pledged shares .

Fixed Compensation

ComponentAmount ($)Notes
Annual cash retainer (Board member)65,600Paid quarterly
Audit Committee chair15,000Paid quarterly
Audit Committee member7,500Paid quarterly
Compensation Committee chair8,000Paid quarterly
Compensation Committee member4,000Paid quarterly
Nominating & Governance chair6,000Paid quarterly
Nominating & Governance member3,000Paid quarterly

Change vs prior policy:

  • 2023 proxy disclosed a $35,000 annual Board retainer (after initial $40,000 in year of appointment) and similar committee fees; the 2025 proxy shows the Board retainer increased to $65,600, indicating a step‑up in director cash compensation .

Performance Compensation

InstrumentGrant sizeVestingPerformance link
Initial option grant upon appointment (non‑employee directors)Up to 2,553 sharesMonthly over 1 yearNo explicit performance metrics; time‑based vesting
Annual option grant at annual meeting (if serving)Number/vesting at Comp Committee discretionAs determinedNo metrics disclosed; committee discretion

No director PSUs/TSR‑linked awards or performance metrics for director pay are disclosed; director equity is time‑vested (options) .

Other Directorships & Interlocks

CompanyRolePotential Interlock/Conflict
BCB Bancorp (NASDAQ: BCBP)Director; Audit leadershipBanking industry; no THAR‑related party transactions disclosed
  • Related‑party transactions: THAR reports no related‑party transactions in 2023–2024 above SEC thresholds; a related‑person transaction policy requires audit committee review of any such items .

Expertise & Qualifications

  • CPA; Certified Mediator; Certified Fraud Examiner; Chartered Global Management Accountant .
  • Financial forensics, valuation, regulatory compliance; co‑author “Project Management Accounting” .
  • Degrees: Rutgers (Accounting/Finance), Notre Dame (MBA), Corpus Christi College, Oxford .

Equity Ownership

HolderShares Beneficially Owned% of OutstandingNotes
Gary StetzNo beneficial ownership reported as of record date (Apr 28, 2025); total shares outstanding 2,209,910
  • Company‑wide: As of the record date, 2,209,910 shares outstanding; equity plan overhang and dilution metrics detailed in proxy (options/warrants outstanding; plan amendment to 792,602 shares reserved) .

Shareholder Vote Signal (Election Support)

DirectorForAbstainBroker Non‑Votes
Gary Stetz760,126 16,671 352,661

All seven nominees were elected at the June 10, 2025 meeting .

Governance Assessment

  • Positives:

    • Independence confirmed; deep audit/finance expertise enhances oversight; prior audit chair/financial expert experience at a public bank strengthens audit effectiveness .
    • Anti‑hedging/pledging policy with no pledges outstanding supports alignment and risk control .
    • Clear related‑party policy; no related‑party transactions reported in 2023–2024 .
    • Shareholder support evidenced by strong “For” vote on election .
  • Potential concerns/monitoring:

    • Ownership alignment: no beneficial ownership reported as of record date; monitor subsequent Form 4 filings for option grants/holdings post‑appointment .
    • Committee assignment transparency: post‑April 2025 committee memberships not disclosed in proxy; confirm whether Stetz joins Audit Committee given credentials .
    • Director pay escalation: Board retainer increased to $65,600 from $35,000 in prior year; assess pay‑for‑workload justification as THAR scales .

RED FLAGS: None disclosed specific to Stetz (no related‑party ties, no legal proceedings, no pledging). The principal watch item is initial lack of reported share ownership at record date, balanced against expected time‑vested option grants upon appointment .